Platelet Malonyldialdehyde Formation: An Indicator of Platelet Hyperfunction

Summary

In 25 normal controls (Group I) and in 23 patients (Groups II and III) platelet malonyldialdehyde formation in the presence of N-ethyl maleimide (NEM) or thrombin was evaluated as an indicator of enhanced platelet function. 12 patients (Group III) with diabetes mellitus, nephrotic syndrome, or acute lymphatic leukemia in remission either exhibited spontaneous platelet aggregation (6/12), or enhanced platelet aggregation to minimal concentrations of ADP and Epinephrine (6/12). In these same Group III patients platelet malonyldialdehyde formation was markedly increased (p <0.0005) when compared to the values in the Group I normal controls. Studies in the 12 abnormal subjects later revealed normal aggregation patterns in 6/12 on follow-up evaluation. Concomitant estimation of platelet malonyldialdehyde at this time revealed a decrease into the normal range for platelet malonyldialdehyde values in the presence of thrombin in these 6 patients. Although significantly decreased from initial levels, (p <0.0005) malonyldialdehyde estimation in the presence of NEM was still slightly above the normal range. In 11 patients (Group II) both platelet aggregation tracings and malonyldialdehyde formation was normal and similar to values in the control population. Platelet malonyldialdehyde is a byproduct of the platelet endoperoxides which are intermediaries in the sequence of platelet prostaglandin synthesis. These results, therefore, suggest that part of the phenomenon of platelet hyperaggregability is intrinsic to the platelet and may involve platelet prostaglandin synthesis. The estimation of platelet malonyldialdehyde is a simple technique which appears to detect platelet hyperfunction.

• References

• 1 Breddin VK, Bauke J. 1965; Thrombozytenagglutination und Gefabkrankheiten. Blut 11: 144
• 2 Breddin K, Grun H, Krzywanek HJ, Schremmer WP. 1976; On the Measurement of Spontaneous Platelet Aggregation. The Platelet Aggregation Test III. Thrombosis Haemostasis 35: 669
• 3 Born GV R. 1962; Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal. Nature 194: 927
• 4 Halushka PV, Lurie D, Colwell JA. 1977; Increased synthesis of protaglandin-E-like material by platelets from patients with diabetes mellitus. New England Journal of Medicine 297: 1306
• 5 Hamberg M, Samuelsson B. 1973; Detection and isolation of an endoperoxide intermediate in prostaglandin biosynthesis. Proceedings of the National Academy of Science, USA 70: 899
• 6 Friedlander Cook IJ Y, Hawkey C, Symons C. 1971; A Laboratory Study of Spontaneous Platelet Aggregation. Journal of Clinical Pathology 24: 323
• 7 Hope WC, Dalton C, Machlin LJ, Filipski RJ, Vane FM. 1975; Influence of vitamin E on prostaglandin biosynthesis in rat blood. Prostaglandins 10: 557
• 8 Machlin LJ, Filipski R, Willis AL, Kuhn DC, Brin M. 1975; Influence of vitamin E on platelet aggregation and thrombocythemia in the rat. Proceedings of the Society for Experimental Biology and Medicine 149: 275
• 9 O’kuma M, Steiner M, Baldini M. 1970; Studies on Lipid Peroxides in Platelets. Method of Assay and Effect of Storage Journal of Laboratory and Clinical Medicine 75: 283
• 10 Rivard GE, Lazeron J. 1975; A simple method for platelet sizing. Journal Laboratory and Clinical Medicine 86: 547
• 11 Smith JB, Ingerman CM, Silver MJ. 1976; Malondialdehyde formation as an indicator of prostaglandin production by human platelets. Journal of Laboratory and Clinical Medicine 88: 167
• 12 Stuart MJ, Murphy S, Oski FA. 1975; A simple non-radioisotope technique for the determination of platelet life-span. New England Journal of Medicine 292: 1310
• 13 Vreeken J, van Aken WG. 1971; Spontaneous aggregation of blood platelets as a cause of idiopathic thrombosis and recurrent painful toes and fingers. Lancet 2: 1394
• 14 Wu KK, Hoak JC. 1974; A new method for the quantitative detection of platelet aggregates in patients with arterial insufficiency. Lancet 2: 924
• 15 Wu KK, Hoak JC. 1976; Spontaneous platelet aggregation in arterial insufficiency: Mechanisms and implications. Thrombosis and Haemostasis 35: 702